BRSAPRACNPR6
BRSAPRACNPR6
SANEPAR PN N2
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 13.07B EUR | 10.79B EUR | 12.86B EUR | 11.83B EUR |
Enterprise Value | 5.07B EUR | 13.43B EUR | 14.83B EUR | 13.62B EUR |
Valuation Multiples | ||||
Trailing P/E | 30.89x | 23.7x | 10.5x | 13.58x |
Forward P/E | 11.09x | -- | -- | -- |
Price to Sales | 1.73x | 1.43x | 1.75x | 2.19x |
Price to Book | 0.22x | 0.89x | 1.01x | 0.96x |
EV/Revenue | 0.67x | 1.78x | 2.02x | 2.52x |
EV/EBITDA | 1.74x | 9.3x | 10.98x | 53.89x |
Price to FCF (P/FCF) | -- | 2.52x | 2.65x | 2.82x |
EV/FCF | -- | 3.14x | 3.06x | 3.25x |
FCF Yield | -2.85% | 39.64% | 37.7% | 35.46% |